The co-existence of carbapenemase, 16S rRNA methylase and mutated quinolone resistancedetermining regions (QRDRs) can cause serious difficulty in treating infections with multidrugresistant Acinetobacter baumannii. In this study, we aimed to determine the mechanisms of imipenem, amikacin and ciprofloxacin resistance in A. baumannii isolates with resistance to these antibiotics. A total of 31 non-duplicate isolates of amikacin-and ciprofloxacin-resistant Acinetobacter isolates were identified from April to August 2010 from a single hospital in South Korea. To assess the clonal relatedness of the 31 Acinetobacter isolates, multilocus sequence typing, network phylogenetic analysis and enterobacterial repetitive intergenic consensus-PCR were utilized. Detection of OXA-type carbapenemase and 16S rRNA methylase was conducted using a multiplex PCR assay. The QRDRs of the gyrA and parC genes were amplified and sequenced. The result showed that 30/31 isolates harboured the bla OXA-23 -like carbapenemase, which made them resistant to imipenem (MICs ¢16 mg ml "1 ). Twenty-eight of the 31 isolates were found to possess armA, a 16S rRNA methylase gene, and showed resistance to amikacin, arbekacin, gentamicin and tobramycin (MICs .256 mg ml "1 ). All of the isolates were determined to carry QRDR mutations in both gyrA and parC: a Ser83Leu substitution in gyrA and a Ser80Leu substitution in parC, causing a ciprofloxacin MIC ¢64 mg ml "1 . In conclusion, A. baumannii with co-existence of carbapenemase, 16S rRNA methylase and mutated QRDRs are extremely prevalent in South Korea, which may cause serious problems in the treatment of A. baumannii infections using carbapenem, amikacin and ciprofloxacin.
INTRODUCTION
Acinetobacter baumannii frequently causes various nosocomial infections worldwide, including ventilator-associated pneumonia, bacteraemia and urinary tract infections (Munoz-Price & Weinstein, 2008; Peleg et al., 2008; Villegas & Hartstein, 2003) . In particular, nosocomial infections caused by this species often occur in patients in intensive care and burn units (Wilks et al., 2006) . Recently, the occurrence of multidrug resistance in A. baumannii has increased dramatically (Lee et al., , 2011 Sung et al., 2011) .
It is known that class D carbapenemase in A. baumannii and class B carbapenemase in non-baumannii are principal agents that cause resistance to carbapenem in these strains . The OXA-type class D carbapenemases of A. baumannii can be divided into the following subgroups: . Of these, OXA-23 and -51 are the most common and frequently occur simultaneously within a single isolate. Whilst OXA-51 is an intrinsic enzyme, OXA-23 is an acquired enzyme and frequently leads to A. baumannii outbreaks in intensive care units around the world (Higgins et al., 2010; Jeon et al., 2005; Lee et al., 2009; Mugnier et al., 2010; Valenzuela et al., 2007; Zong et al., 2008) . tobramycin and gentamicin, has been identified in various Gram-negative bacilli (Galimand et al., 2003; Lee et al., 2006) . Additionally, various 16S rRNA methylase genes, including armA, rtmB and rtmA, have been widely reported in Japan (Doi et al., 2004) , Taiwan (Yan et al., 2004) , South Korea , Europe (Bogaerts et al., 2007) , North America (Doi & Arakawa, 2007) and Brazil .
A. baumannii resistance to quinolones is frequently associated with mutations in the quinolone resistancedetermining region (QRDR) of gyrA and/or parC genes (Deccache et al., 2011; Liu et al., 2012; Ruiz, 2003; Sheng et al., 2009; Sung et al., 2011) .
The co-production of OXA carbapenemase and 16S rRNA methylase in A. baumannii was recently reported (Brigante et al., 2012; Jeong et al., 2011; Kim et al., 2008) . In this study, we aimed to determine the mechanism(s) responsible for the resistance of A. baumannii to carbapenem, aminoglycoside and quinolone. To this end, we performed molecular epidemiological experiments including enterobacterial repetitive intergenic consensus (ERIC)-PCR, mutilocus sequence typing (MLST) and network phylogenetic analysis.
METHODS
Bacterial isolates. A total of 31 non-duplicated A. baumannii strains resistant to amikacin and ciprofloxacin were collected from April to August 2010 from a single hospital in South Korea. Identification of all isolates was initially carried out by biochemical tests using the MicroScan WalkAway (Siemens), and was subsequently confirmed by detection of the bla OXA-51 gene (Turton et al., 2006) .
Antimicrobial susceptibility testing and screening for carbapenemase production. To screen for resistance to amikacin and ciprofloxacin, susceptibility testing for these antibiotics was carried out by a disk diffusion method (CLSI, 2012) . The MICs of amikacin, arbekacin, gentamicin, tobramycin, imipenem, ceftazidime, ciprofloxacin, colistin and tigecycline were determined for the bacterial isolates by the Clinical and Laboratory Standards Institute agar dilution method (CLSI, 2012) . According to the British Society for Antimicrobial Chemotherapy breakpoints, the susceptible and resistance interpretation rates for tigecycline were determined to be MICs of ¡1 and ¢2 mg ml 21 , respectively (Peleg et al., 2008) . Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as reference strains for antimicrobial susceptibility testing. A modified imipenem disk Hodge test was used to screen for carbapenemase and an imipenem-EDTA double disk synergy test was used to screen for metallo-b-lactamase (Lee et al., 2003) .
Amplification and sequencing of antimicrobial resistance genes. For preparation of genomic DNAs, a fresh bacterial colony was suspended in 1 ml distilled water and boiled for 10 min. After centrifugation of the bacterial solution, 2 ml supernatant was used for amplification of the bacterial genomic DNA by PCR with the primers described in Table 1 . A GeneAmp 9700 PCR system (Applied Biosystems) was used for the amplification and the PCR conditions are given in the references in Table 1 . Genes encoding OXA-type carbapenemases were detected with a multiplex PCR using the genomic DNA as template and reaction conditions described by Woodford et al. (2006) . Two genes, ISAba1/bla OXA-23 -like and ISAba1/ bla OXA-51 -like, were amplified by PCR with the primer combinations described in Table 1 (Segal et al., 2005) . The primers used to amplify 16S rRNA methylase (armA and rtmB) were designed in previous studies (Galimand et al., 2003; Yan et al., 2004) (Table 1) . To determine quinolone resistance, the QRDRs of gyrA and parC were amplified by PCR using reaction conditions described previously (Liu et al., 2012; Vila et al., 1995) and the sizes of the expected PCR products were 733 and 450 bp, respectively. The amplified DNA products were purified according to the manufacturer's instructions (Promega) and sequenced using an ABI 3130XL automated DNA sequencer (Applied Biosystems). The sequences were compared with those in GenBank using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
MLST. To investigate the MLST allelic profiles of the Acinetobacter isolates, seven housekeeping genes (gltA, gyrB, gdhB, recA, cpn60, gpi and rpoD) were amplified independently in a 20 ml reaction containing 2 ml genomic DNA template, 200 nM each primer and 10 ml EmeraldAmp GT PCR Master Mix (TaKaRa). The PCR primers were chosen from previous studies (Bartual et al., 2005; Park et al., 2009) . Each sample was subjected to an initial denaturation step of 5 min at 95 uC, followed by 30 cycles of 30 s denaturation at 95 uC, 30 s annealing at 53 uC and 0.5-1 min extension at 72 uC, depending on the product size, followed by a final extension step of 5 min at 72 uC. Sequence data were analysed using the BioEdit program (Hall, 1999) . MLST was performed according to the databases hosted on PubMLST (http://pubmlst.org/).
Network phylogenetic analysis. To study the phylogenetic relationships of the MLST allelic profiles, we constructed a medianjoining network using NETWORK version 4.1.1.0 (Bandelt et al., 1999;  http://www.fluxus-engineering.com/sharenet.htm). The network was generated using a 2830 bp stretch corresponding to the concatenated sequence of seven housekeeping genes.
ERIC-PCR. Genomic DNAs from the Acinetobacter isolates were extracted using a Wizard Genomic DNA Purification kit (Promega), according to the manufacturer's instructions. ERIC-PCR was performed in a 20 ml reaction containing 100 ng genomic DNA, 200 nM each oligonucleotide primer (ERIC1R, 59-ATGTAAGCTCCTGGGGATTCAC-39, and ERIC2, 59-AAGTAAGTGACTGGGGTGAGCG-39; Jeong et al., 2006) , 200 mM dNTPs in 50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris/HCl (pH 8.4) and 2 U ExTaq polymerase (TaKaRa). Each sample was subjected to an initial denaturation step of 5 min at 95 uC, followed by 30 cycles of 1 min denaturation at 92 uC, 1 min annealing at 52 uC and 5 min extension at 70 uC, followed by a final extension step of 5 min at 70 uC. The PCR products were loaded on 1.8 % agarose gels, stained with ethidium bromide and visualized using UV fluorescence.
RESULTS

Genospecies identification, MLST and network phylogenetic analysis/ERIC-PCR
The 31 isolates were classified as A. baumannii by the MicroScan WalkAway and the presence of the bla OXA-51 gene. The biochemical test always identified the Acinetobacter calcoaceticus-A. baumannii complex (Gerner-Smidt & Tjernberg, 1993) . The genospecies can be confirmed by amplified rRNA gene restriction analysis (http://users.ugent. be/~mvaneech/ARDRA/Acinetobacter.html), sequence analysis of the 16S rRNA gene or detection of bla OXA-51 gene. For each isolate, the 16S rRNA gene was amplified by PCR with universal primers 27F and 1492R (Weisburg et al., 1991) .
Using the 16S rRNA gene sequence (1352 nt) as a query in a BLAST search, we found that 30 of the 31 isolates were closely related to A. baumannii (99 % nucleotide sequence identity); only one isolate, 8-68, showed a high sequence similarity to A. calcoaceticus (99 % nucleotide sequence identity). It has been reported that some A. baumannii isolates are genotypically grouped into the A. calcoaceticus-A. baumannii complex (Gerner-Smidt & Tjernberg, 1993) . Thus, we initially included the 8-68 isolate for further studies, and if it was later identified as A. calcoaceticus, we could use it as an outgroup for other analyses. The 31 amikacin-and ciprofloxacin-resistant Acinetobacter isolates were evaluated Based on this result, we suggest that the MLST method is a powerful tool for epidemiological studies of A. baumannii.
In contrast, strain 8-68 belonged to ST207 (allelic profile 6-80-111-7-6-100-11), which is exhibited by A. calcoaceticus. The 16S rRNA gene sequence analysis also indicated that isolate 8-68 was not A. baumannii but A. calcoaceticus, supporting the MLST result.
The relationship among the STs was resolved in a medianjoining network phylogenetic tree generated based on the concatenated sequence of seven housekeeping genes (Fig. 1) . Whilst the ST191 node showed 11 branches, the other three nodes, ST208, ST229 and ST207 (an outgroup), showed a single branch. Among the 28 A. baumannii isolates belonging to ST191, only 18 showed 100 % identity based on the concatenated sequence. For the other ten isolates, six and four isolates contain one and two substitutions, respectively, from the major ST191 node (Fig. 1 ). In addition, eBURST (http://eburst.mlst.net/) was used to analyse clonal complexes (CCes). ST208 and ST191 belonged to A. baumannii CC118, which is the international clone 1 and is spread worldwide. ST229 clustered in CC110, present in several countries and emerging as a new resistant lineage in others (Karah et al., 2012; Stietz et al., 2013) . MLST using concatenated sequences is also useful for Acinetobacter genospecies identification (Diancourt et al., 2010) . Therefore, the 31 isolates could be classified as 30 A. baumannii belonging to three different STs, with two of them belonging to the same CC, and one isolate as A. calcoaceticus.
The 31 Acinetobacter isolates were analysed by ERIC-PCR and the result displayed three different profiles (Fig. 2) . The ERIC-PCR fingerprints with multiple DNA fragments ranged from 300 bp to 5 kb. Three common bands of 600 bp, 800 bp and 1.5 kb were observed in all isolates except one (strain 8-68, A. calcoaceticus) (Fig. 2) . MLST indicated the presence of two A. baumannii lineages that showed similar ERIC-PCR profiles. Therefore, ERIC-PCR is a rapid complementary method to distinguish A. baumannii profiles.
Phenotypic characteristics of the antimicrobial susceptibility of amikacin/ciprofloxacin-resistant isolates
The antimicrobial resistance rates against the 31 Acinetobacter isolates are shown in Table 2 . All of the isolates showed high-level resistance for aminoglycosides (aberkacin, amikacin, gentamicin and tobramycin) and quinolone (ciprofloxacin); for the aminoglycosides, the 50 % MIC (MIC 50 ) was .256 mg ml 21 and for the quinolone, the MIC 50 was 128 mg ml
21
. Thirty of the 31 isolates showed resistance to imipenem (MIC 50 64 mg ml
) and all of the isolates were susceptible to colistin and tigecycline (MIC 50 2 and 1 mg ml
, respectively). All of the isolates except for one imipenemsusceptible isolate showed a positive result in the modified Hodge test. In addition, all isolates displayed a negative EDTA synergy test, and the isolates had MICs ¢16 mg ml 21 for imipenem, suggesting the production of carbapenemase rather than metallo-b-lactamases. Overall, 27/31 isolates showed resistance to all of the tested antimicrobial agents excluding colistin and tigecycline (Table 2) .
Multiplex PCR for identification of antimicrobial resistance genes
Using a multiplex PCR, we found that 30/31 isolates harboured both bla OXA-23 -like and ISAba1 upstream of the bla OXA-23 gene, resulting in a MIC of ¢16 mg ml 21 for imipenem. Twenty-eight of the 31 isolates were found to possess armA, a 16S rRNA methylase gene, which resulted in MICs .256 mg ml 21 for amikacin, arbekacin, gentamicin and tobramycin. All of the 31 isolates carried QRDR mutations in the gyrA and parC genes, leading to the Ser83Leu and the Ser80Leu amino acid substitutions, respectively (Fig. 3) . The mutations conferred bacterial resistance to ciprofloxacin (MIC ¢64 mg ml 21 ). Overall, 27/31 isolates showed co-expression of OXA-23 carbapenemase and 16S rRNA methylase ArmA along with mutations in the QRDRs of gyrA and parC (Tables 2 and 3) . M2 C #3 C #2 C #1 8-73 8-68 7-49 7-47 7-43 6-34 6-27 6-25 6-19 6-18 6-15 6-11 6-03 6-79 6-78 M1 Fig. 2 . ERIC-PCR profiles of genomic DNA from 31 Acinetobacter isolates from South Korea. The 31 Acinetobacter isolates exhibited two or three distinct genotyping patterns, including three control A. baumannii isolates from three other university hospitals (C # 1, ST169; C # 2, ST158; and C # 3, ST373). Lanes M1 and M2 show 1 kb and 100 bp ladder molecular size markers, respectively. 
DISCUSSION
A. baumannii has emerged globally as one of the most troublesome pathogens due to its remarkable ability to acquire genetic determinants for antibiotic resistance. Carbapenem, aminoglycosides and quinolone antibiotics have been used efficiently in the treatment of infection with A. baumannii. However, multidrug-resistant A. baumannii isolates resistant to these antibiotics have been increasingly reported in various countries including China, Thailand and South Korea (Apisarnthanarak & Mundy, 2009; Sung et al., 2011; Zhao et al., 2011) .
In this study, we tried to identify the genes responsible for the resistance of A. baumannii isolates to carbapenem, aminoglycosides and quinolone. All isolates except one were resistant to carbapenem due to acquisition of OXAtype carbapenemase. Additionally, most isolates had highlevel resistance to aminoglycosides and ciprofloxacin due to the expression of a 16S rRNA methylase and the mutations within the QRDRs of the gyrA and parC genes.
It was reported recently that OXA carbapenemase-producing A. baumannii have increased dramatically and have disseminated across many Korean hospitals (Kim et al., 2010; Lee et al., 2009) . Approximately 74 % of the imipenem-non-susceptible (IPM-NS) isolates collected from 17 hospitals in 2005 produced OXA-type carbapenemases, 34 % of which harboured bla OXA-23 . In 2007, 97 % of IPM-NS isolates collected from 12 hospitals produced OXA-carbapenemases, 80 % of which produced OXA-23 carbapenemase (Kim et al., 2010) . In this study, all IPM-NS isolates produced OXA-23 carbapenemase and had ISAba1 upstream of the bla OXA-23 gene, resulting in MICs ¢16 mg ml 21 for imipenem. All of our isolates also harboured bla OXA-51 , but only one isolate had ISAba1 upstream of bla OXA-51 .
The presence of a 16S rRNA methylase mediating highlevel resistance to aminoglycosides has been detected in clinical isolates of A. baumannii Sung et al., 2011) . It was reported that 53.8 % of amikacinresistant A. baumannii produced 16S rRNA methylase ArmA . In addition, it was reported that 93 % of IPM-NS isolates collected in hospitals produced 16S rRNA methylase ArmA and 50 % of the isolates contained both armA and bla OXA-23 (Sung et al., 2011) . In this study, 87 % of the amikacin-resistant A. baumannii isolates contained the armA gene, and isolates containing the armA gene showed high-level resistance to all tested aminoglycosides, including aberkacin, amikacin, gentamicin and tobramycin (MICs .256 mg ml 21 ). In addition, 30/31 isolates harboured bla OXA-23 . Several hospital disseminations of A. baumannii co-producing OXA-23 carbapenemase and 16S rRNA methylase ArmA were reported in South Korea in 2007 Kim et al., 2008) and in Italy in 2009 (Brigante et al., 2012) .
Rapidly increasing resistance of A. baumannii to quinolone is associated with chromosomal mutations within the QRDRs of gyrA and parC: a single amino acid substitution in GyrA (Ser83Leu) is associated with high-level resistance to ciprofloxacin, and an additional amino acid substitution in ParC, usually Ser80Leu, is also associated with higher resistance to this antibiotic (Liu et al., 2012; Ruiz, 2003; Vila et al., 1995) . In South Korea, Sung et al. (2011) reported that all 44 A. baumannii isolates with IPM-NS harboured the QRDR mutation in the gyrA and parC genes, leading to high-level resistance to ciprofloxacin (MIC 50 ¢32 mg ml
21
). In our study, all of the A. baumannii isolates harboured the QRDR mutations in the gyrA and parC genes and showed high-level resistance to ciprofloxacin (MIC 50 128 mg ml 21 ), which is congruent )  80  70  60  50  40  30  20  10  90   80  70  60  50  40  30  20  10 90 with the observations in previous studies (Liu et al., 2012; Ruiz, 2003; Sung et al., 2011; Vila et al., 1995) .
We assessed the clonal relatedness of the 31 amikacin-and ciprofloxacin-resistant Acinetobacter isolates via ERIC-PCR profiles and MLST analysis. The A. baumannii MLST results produced higher resolution than those of ERIC-PCR for epidemiological studies. In addition, the clustering of A. baumannii isolates produced by MLST was in perfect agreement with the features of the antimicrobial resistance gene profiles (Table 3) . Combined ST profiles from MLST, network and eBURST analyses showed the most detailed level of the clonal relatedness of the 30 A. baumannii isolates (Fig. 2 ).
In conclusion, co-production of OXA-23 carbapenemase and 16S rRNA methylase ArmA may be a factor causing the resistance of A. baumannii to carbapenem and aminoglycosides. Additionally, the QRDR mutations within gyrA and parC genes are potential ways to increase the resistance of A. baumannii to quinolone. 
